natgillin/translations-raw huggingface dataset:
Slipped capital femoral epiphyses and aseptic necrosis of the femoral head may be seen in children with advanced renal osteodystrophy and in growth hormone deficiency, and it is uncertain whether these problems are affected by GH therapy.
Pri otrocih z napredovalo ledvično osteodistrofijo in pomanjkanjem rastnega hormona se lahko pojavi zdrs epifize glavice stegnenice in aseptična nekroza glavice stegnenice, vendar pa vpliv zdravljenja z rastnim hormonom nanju ni pojasnjen.
However, no somatropin accumulation has been reported in children with chronic renal failure or end-stage renal disease dosed with current regimens.
Vendar pri otrocih s kronično odpovedjo ledvic ali končnim stadijem ledvične bolezni, ki so dobivali odmerke po trenutnih shemah, niso opažali kopičenja somatropina.
• Avoid touching the cartridge rubber seal at all times.
• Ne dotikajte se gumijaste zapore vložka.
Remove the paper seal from a new needle assembly and screw it onto the cartridge holder.
Odstranite papirnato zaščitno nalepko s kompleta z novo iglo in iglo privijte na držalo vložka.
These events can be avoided by correct injection technique and rotation of injection sites.
Pojav teh neželenih učinkov se lahko prepreči s pravilno tehniko injiciranja in rednim menjavanjem mest injiciranja.
What NutropinAq contains
Kaj vsebuje zdravilo NutropinAq
Holding the pen with the needle pointing upward, gently tap the cartridge holder to move any air bubbles to the top.
Držite injekcijski peresnik tako, da bo igla obrnjena navzgor in previdno potrkajte ob držalo vložka, da se bodo morebitni mehurčki dvignili na vrh.
Although rare, pancreatitis should be considered in somatropintreated children who develop abdominal pain.
Primeri so sicer redki, vendar pa je pri otroku, ki se zdravi s somatropinom, v primeru pojava bolečine v trebuhu treba pomisliti na vnetje trebušne slinavke.
Hypothyroidism may develop during treatment with NutropinAq and untreated hypothyroidism may prevent optimal response to NutropinAq.
Nezdravljeni hipotiroidizem lahko prepreči optimalen odziv na zdravilo NutropinAq.
Caution should be exercised while breast-feeding during treatment with NutropinAq.
Med zdravljenjem z zdravilom NutropinAq je potrebna previdnost pri dojenju.
6 cartridges containing 2 ml solution for injection
6 vložkov z 2 ml raztopine za injiciranje
Pancreatitis in children
Vnetje trebušne slinavke pri otrocih
Protein metabolism
Presnova beljakovin
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS {CARTRIDGE}
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
Set the required dose by turning the black dose knob.
S sukanjem črnega odmernega gumba nastavite potrebni odmerek.
Your doctor or nurse will advise you regarding pen storage.
Zdravnik ali medicinska sestra vam bosta povedala vse potrebno o shranjevanju injekcijskega peresnika.
3 cartridges containing 2 ml solution for injection
3 vložki z 2 ml raztopine za injiciranje
NutropinAq reduces insulin sensitivity; glucose tolerance impairment was reported in both the pivotal and supportive clinical trials and the post-marketing surveillance survey.
O moteni toleranci za glukozo so poročali tako v ključnih kot podpornih kliničnih preskušanjih in med spremljanjem zdravila v obdobju trženja.
You should stop taking NutropinAq if you are pregnant.
Med nosečnostjo zdravila NutropinAq ne smete uporabljati.
<2D barcode carrying the unique identifier included>
EDINSTVENA OZNAKA - DVODIMENZIONALNA ČRTNA KODA Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
• Your doctor should monitor you for high blood sugar levels (hyperglycemia) during treatment with NutropinAq.
Zdravnik bo med zdravljenjem z zdravilom NutropinAq spremljal znake visoke vrednosti krvnega sladkorja.
Insert cartridge into the cartridge holder, then screw the cartridge holder back onto the pen.
Vstavite vložek v držalo vložka in držalo vložka privijte nazaj na injekcijski peresnik.
If your hypothyroidism is not treated, it could stop NutropinAq from working.
Nezdravljeni hipotiroidizem lahko prepreči delovanje zdravila NutropinAq.
One ml contains 5 mg of somatropin One cartridge contains 10 mg (30 IU) of somatropin
En vložek vsebuje 10 mg (30 i.e.) somatropina.
Either of the NutropinAq cartridge designs can be used with either of the NutropinAq Pen designs.
NutropinAq vložki v obeh zunanjih podobah se lahko uporabljajo z injekcijskim peresnikom NutropinAq Pen v obeh zunanjih podobah.
Somatropin must not be used when there is any evidence of activity of a tumour.
Če obstajajo dokazi o aktivnosti tumorja, se somatropina ne sme uporabljati.
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS {BLISTER}
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
Patients received an s.c. dose of 0.125 mg/kg three times a week or 0.054 mg/kg/day, both regimens giving a cumulative weekly dose of approximately 0.375 mg/kg.
Obe shemi zagotavljata kumulativni tedenski odmerek približno 0,375 mg/kg.
When travelling, place your pen case in a cooler.
Na potovanju hranite škatlico z injekcijskim peresnikom v hladilni posodi.
In children, NutropinAq is used:
Pri otrocih zdravilo NutropinAq uporabljamo:
Use a cooler to store your NutropinAq Pen when travelling.
Med potovanjem hranite injekcijski peresnik NutropinAq Pen v hladilni posodi.
A: The battery in your NutropinAq Pen is losing its charge.
O: Baterija v injekcijskem peresniku izgublja napetost.
Oedema was reported as common in children.
Pri otrocih so o pojavu edema poročali kot o pogostem neželenem učinku.
EXP: {date} After first opening, use before 28 days at 2°C - 8°C.
Uporabno do: {datum} Po prvem odprtju shranjujte v hladilniku (2 °C - 8 °C) in porabite v 28 dneh.
Intracranial hypertension with papilloedema, visual changes, headache, nausea and/or vomiting has been reported in a small number of patients treated with somatropin.
Pri majhnem številu bolnikov, zdravljenih s somatropinom, so poročali o intrakranialni hipertenziji s papiledemom, spremembami vida, glavobolom, navzeo in/ali bruhanjem.
Leukaemia has been reported in a small number of growth hormone deficient patients treated with growth hormone.
Pri manjšem številu bolnikov s pomanjkanjem rastnega hormona, ki so se zdravili z rastnim hormonom, so poročali o pojavu levkemije.
Uncommon: Slipped capital femoral epiphysis, scoliosis progression, arthralgia Rare: Bone development abnormal, osteochondrosis, muscular weakness, pain in extremity
Redki: nenormalen razvoj kosti, osteohondroza, mišična oslabelost, bolečina v okončinah
Keep the blister in the outer carton.
Pretisni omot shranjujte v škatli.
Freezing will damage the pen and medicine.
O: Ne. Zamrzovanje okvari injekcijski peresnik in zdravilo.
The most commonly reported AEs were flu syndrome, infection, headache, pharyngitis, rhinitis and otitis media.
Najpogosteje so poročali o naslednjih neželenih učinkih: gripi podobnemu sindromu, okužbi, glavobolu, faringitisu, rinitisu in vnetju srednjega ušesa.
Funduscopic examination is recommended at the initiation and periodically during the course of treatment.
Na začetku in redno med zdravljenjem so priporočljivi pregledi očesnega ozadja.
Localised loss/gain of fat from the skin (lipodystrophy, injection site atrophy/hypertrophy) Enlarged adenoids with similar symptoms as enlarged tonsils (see rare).
Povečanje adenoidnega tkiva s podobnimi simptomi, kot pri povečanju tonzil (glejte redki).
This was accompanied by a significant increase in height SDS from -0.1 to 0.5 at baseline to 0.0 to 0.7 at Month 12 and 1.6 to 1.7 at Month 48.
To je spremljalo pomembno povečanje vrednosti SDS telesne višine od -0,1 do 0,5 v izhodišču do vrednosti od 0,0 do
Always refer to the LCD (Liquid Crystal Display), not audible clicks, for setting an injection of NutropinAq.
Za nastavitev odmerka zdravila NutropinAq se ne smete zanašati na slišne klike, ampak morate vedno uporabiti prikazovalnik LCD (prikazovalnik s tekočimi kristali).
Gently swirl.
nadlaket trebuh stegno
• Phamacovigilance System
• Sistem farmakovigilance
No effect on ability to drive or use machines has been noticed while using NutropinAq.
Vplivov zdravila NutropinAq na sposobnost upravljanja vozil in strojev niso opazili.
Feeling of weakness (asthenia) and increased muscle tension (hypertonia)
Pomanjkanje ali izguba moči ali energije (astenija) in zvečan tonus mišic (hipertonija).
1 cartridge containing 2 ml solution for injection
1 vložek z 2 ml raztopine za injiciranje
Two pivotal, multicentre, controlled studies have been conducted in patients with growth failure associated with chronic renal insufficiency (CRI).
Pri bolnikih z zaostankom v rasti, povezanim s kronično ledvično insuficienco, sta bili izvedeni dve ključni, multicentrični nadzorovani študiji.
Use a damp cloth to wipe away dirt.
Umazanijo odstranite z vlažno krpico.
The site of injection should be changed.
Raztopino za injiciranje je treba aplicirati subkutano vsak dan. Mesto injiciranja je treba menjati.
Reactions observed from the post marketing environment
Neželeni učinki, opaženi med spremljanjem zdravila po prihodu na trg
Read all the instructions for use carefully (on the reverse) before you start using NutropinAq Pen.
Preden začnete uporabljati injekcijski peresnik NutropinAq Pen, natančno preberite navodila za njegovo uporabo (na hrbtni strani navodila).
Uncommon: Neoplasm malignant, neoplasm benign
Občasni: maligni tumor, benigni tumor
How to store NutropinAq
Shranjevanje zdravila NutropinAq
Ask advice from you doctor before you stop using NutropinAq.
Preden prenehate uporabljati zdravilo NutropinAq, se posvetujte s svojim zdravnikom.
Injection site reactions such as haemorrhage, atrophy, urticaria and pruritus were reported in the pivotal and supportive clinical trials and/or the post-marketing surveillance survey.
V ključnih in podpornih kliničnih preskušanjih in/ali med spremljanjem zdravila v obdobju trženja so poročali o reakcijah na mestu injiciranja, kot so krvavitev, atrofija, urtikarija in srbenje.
Attach the pen cap and return it to its case with the black dose knob pressed in. You should always store the pen in a refrigerator.
Namestite pokrovček injekcijskega peresnika in ga, s črnim odmernim gumbom potisnjenim navznoter, položite nazaj v škatlico.
Sodium Citrate Dihydrate Citric Acid, Anhydrous Water for Injections
6.1 Seznam pomožnih snovi natrijev klorid tekoči fenol polisorbat 20 natrijev citrat dihidrat brezvodna citronska kislina voda za injekcije
The average treatment time was 4.7 years in the somatropin three times a week group and 4.6 years in the somatropin daily group.
Zdravljenje je v povprečju trajalo 3,2 in 4,6 let, skupna izpostavljenost pa je znašala 542 bolnikov-let.
Patients should have periodic thyroid function tests and should be treated with thyroid hormone when required.
Pri bolnikih je treba redno opravljati preiskave delovanja ščitnice in po potrebi uvesti ustrezno zdravljenje.
- Keep this leaflet.
Previdno vrtite.
A: No.
NN: {številka}
Therefore, patients should have periodic thyroid function tests and should be treated with thyroid hormone when indicated.
Zato morajo bolniki redno opravljati preiskave delovanja ščitnice.
Drink straight away.
Takoj popijte.
The effect was significant from the first year.
Učinek je bil signifikanten od prvega leta naprej.
The cause of this finding is unknown.
Vzrok tovrstnih izsledkov ni znan.
The risk of fractures is increased with the number of risk factors.
Tveganje za zlome se povečuje s številom dejavnikov tveganja.
Just carry on with the next dose at the normal time.
Preprosto nadaljujte z naslednjim odmerkom ob običajnem času.
Add water;
Dolijte vodo.
If this is not possible, it is acceptable to take the two medicines at the same time.
Kadar to ni mogoče, je sočasno jemanje obeh zdravil sprejemljivo.
Additional risk minimisation measures
Dodatni ukrepi za zmanjševanje tveganja
Interaction with laboratory test
Interakcije z laboratorijskimi preiskavami
The newly formed bone is of normal quality.
Novonastala kost je normalne kakovosti.
System Organ Class (SOC) Frequency category
Razred organskega sistema (SOC - System Organ Class) Kategorija pogostnosti
6.3 Shelf life - 3 years.
6.3 Rok uporabnosti - 3 leta.
Stir until the granules are evenly dispersed in the water.
Mešajte, dokler se zrnca enakomerno ne porazdelijo v vodi.
Strontium has a volume of distribution of about 1 l/kg.
Stroncij ima volumen porazdelitve približno 1 l/kg.
Your doctor will tell you how long you should continue to take OSSEOR.
Zdravnik vam bo povedal, koliko časa morate jemati OSSEOR.
• When to seek urgent medical advice.
• kdaj je potrebno poiskati nujno zdravniško pomoč,
Early withdrawal is associated with a better prognosis.
Zgodnja prekinitev jemanja zdravila je povezana z boljšo prognozo.
Your doctor will not prescribe OSSEOR for you if you are at particular risk.
Vaš zdravnik vam ne bo predpisal zdravila OSSEOR, če ste še posebej ogroženi.
You can take OSSEOR again when you have finished taking these antibiotics.
OSSEOR lahko ponovno začnete jemati, ko prenehate z jemanjem tovrstnih antibiotikov.
• Importance of regularly monitoring cardiovascular risk.
• pomen rednega spremljanja tveganja za srčno-žilne dogodke.
Patients should be advised of the signs and symptoms and monitored closely for skin reactions.
Bolnike moramo obvestiti o znakih in simptomih ter pozorno spremljati njihove kožne reakcije.
This is especially common in women after the menopause.
Zlasti pogosto se to dogaja pri ženskah v obdobju po menopavzi.
Many people with osteoporosis have no symptoms and you may not even know that you have it.
Mnogi bolniki z osteoporozo nimajo simptomov in mogoče je, da sploh ne veste, da bolezen že imate.
The effective half-life of strontium is about 60 hours.
Efektivna razpolovna doba stroncija je približno 60 ur.
OSSEOR has been studied in clinical trials involving nearly 8,000 participants.
OSSEOR so proučevali v kliničnih študijah, ki so zajele skoraj 8000 bolnikov.
Your body is constantly breaking down old bone and making new bone tissue.
Telo neprestano razgrajuje staro kost in tvori novo kostno tkivo.
In rats, these effects were reversible 8 weeks after cessation of treatment.
Pri podganah so ti učinki izginili 8 tednov po prekinitvi zdravljenja.
Children and adolescents OSSEOR is not intended for use in children and adolescents (below the age of 18).
OSSEOR ni namenjen otrokom in mladostnikom (mlajšim od 18 let).
After approval of the protocol, annual reports from this study shall be provided within the PSUR until submission of the final study report, which is due by December 2017.
Po odobritvi protokola je potrebno letna poročila iz te študije predložiti skupaj s periodičnim poročilom o varnosti zdravila (PSUR) pred predložitvijo končnega poročila o študiji, ki je predvidena decembra 2017.
OSSEOR with food and drink:
Zdravilo OSSEOR skupaj s hrano in pijačo
All patients received daily supplemental calcium (1000 mg) and vitamin D (800 UI).
Vsi bolniki so dnevno prejemali dodatek kalcija (1000 mg) in vitamina D (800 i.e.).
Mean age was 75 years at inclusion and 23% of the patients enrolled were 80 to 100 years of age.
Srednja starost ob vključitvi je bila 75 let in 23 % vključenih bolnic je bilo starih od 80 do 100 let.
Boxes containing 7, 14, 28, 56, 84 or 100 sachets.
Škatle vsebujejo 7, 14, 28, 56, 84 ali 100 vrečk.
Date of latest renewal: 21/09/2009
Datum prve odobritve: 21/09/2004 Datum zadnjega podaljšanja: 21/09/2009
INFORMATION IN BRAILLE OSSEOR 2 g
PODATKI V BRAILLOVI PISAVI OSSEOR 2 g
How OSSEOR works
Kako OSSEOR deluje
The rash may progress to widespread blistering or peeling of the skin.
Izpuščaj lahko napreduje do razširjenih mehurjev ali luščenja kože.
Heart attack may occur commonly in patients at high risk for heart disease.
Srčni infarkt lahko pogosto nastopi pri bolnikih z visokim tveganjem za bolezen srca.
Strontium ranelate does not present a risk for the environment.
Stroncijev ranelat ne predstavlja tveganja za okolje.
In each Member State where OSSEOR is marketed, the Marketing Authorisation Holder (MAH) shall agree the final educational programme with the National Competent Authority.
V posamezni državi članici, kjer se zdravilo OSSEOR trži, se mora imetnik dovoljenja za promet z zdravilom (MAH) dogovoriti s pristojnim nacionalnim organom o končnem izobraževalnem programu.
Non-interventional safety study to evaluate the effectiveness of the applied risk minimisation measures, including a description of the treated patient population in everyday clinical practice, patterns of use and cardiovascular risk.
Neintervencijsko klinično preskušanje o varnosti zdravila za oceno učinkovitosti ukrepov za zmanjševanje tveganja, vključno z opisom zdravljene populacije bolnikov v vsakdanji klinični praksi, načinov uporabe in srčno-žilnega tveganja.
If for some reason you cannot drink the medicine straight away, make sure you stir it again before drinking.
Če iz kakršnegakoli vzroka zdravila ne morete popiti takoj, ga morate pred pitjem ponovno premešati.
• Importance of showing the patient alert card to any Health Care Professional involved in their treatment.
• pomembnost izkazovanja bolnikove kartice z opozorili kateremukoli zdravstvenemu delavcu, ki sodeluje pri zdravljenju,
The activity of strontium ranelate was studied in various non-clinical models.
Dejavnost stroncijevega ranelata so proučevali pri različnih nekliničnih modelih.
Take the granules contained in the sachets as a suspension in a glass of water (see instructions below).
Zrnca iz vrečk zaužijte kot suspenzijo v kozarcu vode (glejte spodnja navodila).
The decision to prescribe strontium ranelate should be based on an assessment of the individual patient's overall risks (see sections 4.3 and 4.4).
Odločitev o predpisovanju stroncijevega ranelata mora temeljiti na podlagi ocene skupnega tveganja za posameznega bolnika (glejte poglavji 4.3 in 4.4).
• All patients should be fully informed that cardiovascular risks should be monitored on a regular basis generally every 6-12 months.
• Vsi bolniki morajo biti v celoti obveščeni, o tem, da je potrebno tveganje za srčno-žilne dogodke spremljati v rednih časovnih presledkih, vsakih 6 do 12 mesecev.
However, it is recommended to drink the suspension immediately after preparation (see section 3)
Vseeno je suspenzijo priporočljivo popiti takoj po pripravi (glejte 3. poglavje).
If you are of Asian origin, talk to your doctor before taking OSSEOR as you may be at higher risk of skin reactions.
Če ste azijskega porekla, se pred začetkom jemanja zdravila OSSEOR posvetujte s svojim zdravnikom, ker je pri vas tveganje za kožne reakcije lahko večje.
• The contraindications to the treatment with OSSEOR.
• kontraindikacije za zdravljenje z zdravilom OSSEOR,
It is important that you continue taking OSSEOR for as long as your doctor prescribes the medicine.
Pomembno je, da z jemanjem zdravila OSSEOR nadaljujete tako dolgo, kot vam je predpisal zdravnik.
What OSSEOR is and what it is used for What you need to know before you take OSSEOR How to take OSSEOR
Kaj je zdravilo OSSEOR in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo OSSEOR Kako jemati zdravilo OSSEOR
The patient alert card shall contain the following key messages:
Opozorilna kartica za bolnike mora vsebovati naslednje pomembne informacije:
Pharmacotherapeutic group: Drugs for the treatment of bone diseases - Other drugs affecting bone structure and mineralisation, ATC code: M05BX03
Farmakoterapevtska skupina: zdravila za zdravljenje bolezni kosti - druga zdravila z učinkom na mineralizacijo kosti, oznaka ATC: M05BX03
Due to the nature of the treated disease, strontium ranelate is intended for long-term use.
Zaradi narave bolezni je stroncijev ranelat namenjen dolgoročnemu zdravljenju.
These potentially lifethreatening skin rashes are often accompanied by flu-like symptoms.
Omenjene morebitno življenje ogrožajoče kožne izpuščaje pogosto spremljajo gripi podobni simptomi.
There were no differences in the nature of adverse reactions between treatment groups regardless of whether patients were aged below or above 80 at inclusion.
Glede na vrsto neželenih učinkov med zdravljenima skupinama ni bilo razlik, ne glede na to, ali so bile bolnice ob vključitvi mlajše ali starejše od 80 let.
However, these effects were mild and short-lived and usually did not cause the patients to stop taking their treatment.
Ti so bili blagi ter prehodni in bolniki zaradi njih običajno niso prekinjali zdravljenja.
The environmental risk assessment of strontium ranelate has been conducted in accordance to European guidelines on ERA.
Ocena tveganja za okolje (ERA - Environmental Risk Assessment) Ocena tveganja za okolje stroncijevega ranelata je bila izvedena v skladu z evropskimi smernicami o ERA.
Uncontrolled hypertension.
Nenadzorovana hipertenzija.
Signs of a blood clot include painful swelling in your leg, sudden chest pain or difficulty breathing.
Znaki krvnega strdka vključujejo boleče otekanje noge, nenadno bolečino v prsih ali težko dihanje.
• The initiation of treatment with OSSEOR should be based on an assessment of the individual patient's overall risk.
• Odločitev o uvedbi zdravljenja z zdravilom OSSEOR mora temeljiti na podlagi ocene skupnega tveganja za posameznega bolnika.
If you have osteoporosis, your body breaks down more bone than it forms so that gradually bone loss occurs and your bones become thinner and fragile.
Če imate osteoporozo, telo razgradi več kosti, kot je tvori, tako da počasi nastaja izguba kostne mase, kosti pa postanejo tanjše in krhkejše.
Although in-use studies have demonstrated that strontium ranelate is stable in suspension for 24 hours after preparation, the suspension should be drunk immediately after being prepared.
Čeprav so študije o uporabi zdravila pokazale, da je stroncijev ranelat v suspenziji stabilen še 24 ur po pripravi, moramo suspenzijo popiti takoj po pripravi.
• Within the prescriber guide there will be a check-list to remind prescribers of the contraindications, warnings and precautions prior to prescribing and to support the regular monitoring of cardiovascular risk.
• Navodila za zdravnika vsebujejo tudi seznam za preverjanje, ki bo zdravnika spomnil na kontraindikacije, opozorila in previdnostne ukrepe preden bo predpisal zdravilo, in zagotovil redno spremljanje tveganja za srčno-žilne dogodke.
You may lie down immediately after taking OSSEOR if you wish.
Če želite, se lahko uležete takoj po jemanju zdravila OSSEOR.
The data on skeletal strontium ranelate accumulation in longer term exposure is limited.
Podatki o kopičenju stroncijevega ranelata v skeletu pri dolgotrajni izpostavljenosti so omejeni.
- if you have or have had problems with your blood circulation (peripheral arterial disease) or if you have had surgery on the arteries of your legs.
- če imate ali ste imeli težave s krvnim pretokom (periferna arterijska bolezen), ali če ste imeli operacijo arterij na nogah;
Single administration of doses up to 11 g in healthy young male volunteers did not cause any particular symptoms.
Jemanje enkratnih odmerkov do 11 g ni povzročilo posebnih simptomov niti pri zdravih mladih moških prostovoljcih.
It is recommended that you take OSSEOR in-between meals, preferably at bedtime at least two hours after food, milk or milk products or calcium supplements.
Priporočljivo je, da OSSEOR jemljete v času med dvema obrokoma, najbolje pred spanjem, najmanj dve uri po zaužitju hrane, mleka ali mlečnih izdelkov in dodatkov kalcija.
Pharmacokinetics in special clinical situations
Farmakokinetika pri posebnih kliničnih skupinah Starejši
OSSEOR is for oral use.
OSSEOR je namenjen za peroralno uporabo.
If you have stopped treatment due to hypersensitivity reactions, do not take OSSEOR again
Če ste prenehali z zdravljenjem zaradi preobčutljivostnih reakcij, zdravila OSSEOR ne jemljite več.
Percentage of Patients Experiencing the adverse reaction Treatment Strontium ranelate (n=3352)
Odstotek bolnic, ki so doživele neželene učinke Zdravljenje stroncijev ranelat (n=3352)
Therapy should not be restarted until the initiating condition has resolved and the patient is fully mobile.
Zdravljenja ne smemo ponovno uvesti, dokler bolezen ali stanje ne izzveni in je bolnik popolnoma pokreten.